my timesThe Korea Times
South KoreaHealth

Health

Korea Times
About Us
Introduction
History
Contact Us
Products & Services
Subscribe
E-paper
RSS Service
Content Sales
Site Map
Policy
Code of Ethics
Ombudsman
Privacy Policy
Youth Protection Policy
Terms of Service
Copyright Policy
Family Site
Hankookilbo
Dongwha Group
FacebookXYoutubeInstagram
CEO & Publisher: Oh Young-jinDigital News Email: webmaster@koreatimes.co.krTel: 02-724-2114Online newspaper registration No: 서울,아52844Date of registration: 2020.02.05Masthead: The Korea TimesCopyright © koreatimes.co.kr. All rights reserved.

New virus cases bounce back to over 400; new vaccine deals signed

A medical worker in a booth takes a nasal sample from a man at a coronavirus testing site in Seoul, Monday, Feb. 15, 2021. APSouth Korea's daily new coronavirus cases bounced back to over 400 on Tuesday after the four-day long Lunar New Year holiday, while the government signed deals to secure additional COVID-19 vaccines to better fight the pandemic. The country reported 457 more COVID-19 cases, including 429 local infections, raising the total caseload to 84,325, the Korea Disease Control and Prevention Agency (KDCA) said.The country added seven more deaths, raising the total to 1,534. Tuesday's daily caseload was higher than the level seen over the past three days when the daily cases remained in the 300s, in part because fewer people were tested for the coronavirus over the holiday that ran from Thursday.The virus curve has been slowly flattening since the third wave of pandemic peaked in late December, but the daily new cases remain higher than those in early November when fewer than 200 cases were reported. A series of infections at religious facilities and hospitals have pose

Feb 16, 2021
New virus cases bounce back to over 400; new vaccine deals signed
  • Korea to hold off inoculating elderly with AstraZeneca vaccines

Celltrion wins sales approval for Humira biosimilar in Europe

A Celltrion plant in Cheongju, North Chungcheong Province / Courtesy of CelltrionBy Nam Hyun-wooCelltrion said Monday it has won an (EMA) approval for CT-P17, a biosimilar to AbbVie's Humira, which is the top-selling drug in the world.Celltrion obtained marketing authorization from the European Commission for CT-P17 on Feb. 11. CT-P17 will be marketed in the region under the name Yuflyma. The green light came two months after the European Medicines Agency's Committee for Medical Products for Human Use recommended the authorization of CT-P17. The authorization covers all of Humira's target diseases including rheumatoid arthritis and inflammatory bowel disease. CT-P17 is the first high-concentration biosimilar of Humira and provides pain-reducing features as it comes with a citrate-free formulation, meaning it causes less pain upon injection.“Celltrion has been focusing on high-concentration type in developing CT-P17, and the authorization has recognized the distinguished competitiveness of this drug,” a Celltrion official said. “We will accelerate our distribution pr

Feb 15, 2021By Nam Hyun-woo
Celltrion wins sales approval for Humira biosimilar in Europe

Korea to hold off inoculating elderly with AstraZeneca vaccines

Korea Disease Control and Prevention Agency (KDCA) Commissioner Jeong Eun-kyeong speaks at a briefing on the vaccination plans held at its office in Cheongju, North Chungcheong Province, Monday. YonhapVaccinations to begin with people under 65 at nursing homesBy Lee Hyo-jin Korea has decided to hold off on administering AstraZeneca's coronavirus vaccine to people over the age of 65, Monday, changing its initial plan to prioritize the elderly population in the first round of vaccinations set to begin later this month. The changed plan has come amid growing controversy worldwide over the efficacy of the pharmaceutical company's product for senior citizens.The Korea Disease Control and Prevention Agency (KDCA) announced detailed plans for the country's first round of vaccinations which is scheduled to roll out Feb. 26, as the first batch of AstraZeneca's doses available for around 750,000 people is expected to arrive on Feb. 24. Patients and medical workers at nursing homes who are younger than 65 will be the first group to get the two-dose vaccines, while plans for inoculating older pe

Feb 15, 2021By Lee Hyo-jin
Korea to hold off inoculating elderly with AstraZeneca vaccines
  • New infections in 300s for 3rd day; distancing rules eased for small businesses
  • New virus cases bounce back to over 400; new vaccine deals signed

South Korea to begin inoculations on Feb. 26, administering AstraZeneca's vaccine to seniors on hold

The Korea Disease Control and Prevention Agency's Director Jeong Eun-kyeong speaks during a press conference at the agency's headquarters in Cheongju, North Chungcheong Province, Feb. 15, about the country's inoculation plan for February and March against COVID-19. YonhapSouth Korea will begin its first inoculations against the new coronavirus on Feb. 26 with AstraZeneca's COVID-19 vaccine, but the inoculation of seniors will be put on hold amid efficacy concerns, health authorities said Monday.The Korea Disease Control and Prevention Agency (KDCA) said people and patients, excluding those aged 65 and older, at nursing homes and other high-risk facilities will receive the first batch of the vaccine developed by the British-Swedish pharmaceutical giant and Oxford University.The decision to put the vaccination of seniors on hold could possibly hamper the country's inoculation plan, which had initially called for a total of 760,000 health care workers and the elderly to be among the first to receive vaccinations between February and March.A total of 272,000 patients and people working a

Feb 15, 2021
South Korea to begin inoculations on Feb. 26, administering AstraZeneca's vaccine to seniors on hold
  • Clubs, room salons allowed to reopen amid eased distancing rules
  • New infections in 300s for 3rd day; distancing rules eased for small businesses

Cat tests positive for COVID-19 in Seoul's 1st case involving pet

The Seoul city government said it has reported its first COVID-19 case on pet ― a female, 4-to-5 years old cat that was living with a family infected with the disease. YonhapA cat living with a family infected with COVID-19 has tested positive for the coronavirus in Seoul's first case involving a pet, the city government said Monday. The female, 4-to-5-year-old cat was tested Saturday after she showed symptoms, including vomiting and lethargy.The result came back positive Sunday, and the cat was sent to a city-run animal welfare center to quarantine, according to the local government."The cat is being taken care of at the animal welfare center because its owners have all tested positive and are unable to look after her," a city official said, noting that infected pets are otherwise expected to isolate at home.The municipal government has tested three dogs and one cat since it began a testing program for pets last Monday.The country's first COVID-19 case involving a pet was reported in a kitten in the southeastern city of Jinju last month.The cat in Seoul appears to have a mild case o

Feb 15, 2021
Cat tests positive for COVID-19 in Seoul's 1st case involving pet

New infections in 300s for 3rd day; distancing rules eased for small businesses

President of minor People's Party and one of the upcoming Seoul mayoral election runners Ahn Cheol-soo, second from right, on Feb. 14 visits popular shopping district Myeongdong in Seoul's Jung District that has been hit hard by COVID-19's economic impact, with many restaurants and other stores forced to close. YonhapSouth Korea's daily new coronavirus cases stayed in the 300s for the third consecutive day Monday on fewer tests during the Lunar New Year holiday, with social distancing measures eased to help small businesses whose operations have been in limbo over tougher regulations.The country reported 344 more COVID-19 cases, including 323 local infections, raising the total caseload to 83,869, the Korea Disease Control and Prevention Agency (KDCA) said.The country added five more deaths, raising the total to 1,527.The number of new cases has remained in the 300s since Saturday in part because fewer people were tested for the coronavirus over the Lunar New Year holiday, which lasted for four days from Thursday.New virus infections have been slowing down since the third wave of the

Feb 15, 2021
New infections in 300s for 3rd day; distancing rules eased for small businesses
  • Clubs, room salons allowed to reopen amid eased distancing rules
  • Korea to hold off inoculating elderly with AstraZeneca vaccines
  • South Korea to begin inoculations on Feb. 26, administering AstraZeneca's vaccine to seniors on hold

Police raid religious group over breach of virus rules

Officials from Daejeon Metropolitan Police Agency search inside the International Mission headquarters in Daeheung area in Daejeon's Jung District, Feb. 15. YonhapPolice on Monday raided the headquarters of a local Christian missionary group over suspected violations of antivirus protocols that led to a large outbreak of the coronavirus.Investigators have been seizing computer hard drives and documents from the International Mission headquarters in Daejeon, 164 kilometers south of Seoul, according to the police.IM has been blamed for more than 400 cases of the coronavirus at its facilities, including at the IEM School in Daejeon.The city government earlier filed a complaint with the police, accusing the leaders of IM and IEM School of violating the law on infectious disease prevention and control.The school held in-person worship services when only virtual services were allowed, and ignored a 20-percent seating cap during a period of eased social distancing, according to city officials.Officials from Daejeon Metropolitan Police Agency get ready to enter the International Mission head

Feb 15, 2021
Police raid religious group over breach of virus rules

INTERVIEW 'Microbiome to be game changer in immunotherapy'

Genome & Company CEO Pae Ji-soo speaks during an interview with The Korea Times at the newspaper's newsroom in Jung-gu, Seoul, Jan. 25. Korea Times photo by Kim Kang-minGenome & Company CEO pursues microbiome healthcare group By Nam Hyun-wooOne of the most rapidly growing sectors in the biopharmaceutical industry is microbiome medicine. Big name tycoons including Bill Gates and Mark Zuckerberg have already noticed the potential of microbiomes and either invested or donated money to businesses and research in this field, which is quickly evolving into a new money magnet. This is also the case of Genome & Company, a Korea-based microbiome biotech focusing on immuno-oncology drugs to treat cancers. In December last year, Genome & Company made its transfer to Korea's tech-heavy Kosdaq from the KONEX, the country's third bourse for startups and venture companies preparing to list on the junior bourse. In its Kosdaq debut trading session Dec. 23, the company's market cap reached 1.14 trillion won ($1 billion), which was the 44th-largest on the market.Pae Ji-soo, a medical d

Feb 15, 2021By Nam Hyun-woo
[INTERVIEW] 'Microbiome to be game changer in immunotherapy'

Clubs, room salons allowed to reopen amid eased distancing rules

A notice explaining the rules of operation and precautionary measures is posted on the entrance of a nightclub near Hongik University in Seoul, Sunday, a day before it is set to reopen. / YonhapConcerns still linger over another mass outbreak after holidayBy Jun Ji-hyeNighttime entertainment establishments across the country such as nightclubs and room salons, which have been forced to shut down for weeks to stem COVID-19 infections, will resume operations starting Monday, as the government decided to ease restrictions amid mounting complaints from pandemic-hit small business owners. Those facilities will be allowed to operate until 10 p.m. on the condition that they comply with key antivirus measures, such as dance bans and enforcing social distancing rules for patrons.Entertainment districts in the Seoul metropolitan area, which includes Incheon and Gyeonggi Province, have been forced to suspend their operations for the past 12 weeks, while those in other parts of the nation have been forced to shut down for the past 10 weeks amid the third wave of COVID-19 infections that began he

Feb 14, 2021By Jun Ji-hye
Clubs, room salons allowed to reopen amid eased distancing rules
  • Recovery of pandemic-hit labor market tipped to be modest: Bank of Korea
  • New infections in 300s for 3rd day; distancing rules eased for small businesses
  • South Korea to begin inoculations on Feb. 26, administering AstraZeneca's vaccine to seniors on hold

COVID-19 cases in 300s for 2nd day ahead of eased distancing

Main entrance to Soon Chun Hyang University Hospital on Feb. 13. A cluster infection of COVID-19 has been reported from the main building of the hospital in Seoul's Yongsan District, including 29 patients, seven nurses and a visitor. YonhapSouth Korea's daily new coronavirus cases stayed in the 300s for a second straight day on Sunday on fewer tests on the Lunar New Year holiday, with eased social distancing measures in store this week.The country reported 326 more COVID-19 cases, including 304 local infections, raising the total caseload to 83,199, the Korea Disease Control and Prevention Agency (KDCA) said. Daily infections fell from 362 cases the previous day, 403 on Friday, 504 on Thursday when the number of new cases surged to a 15-day high despite extended tough virus curbs. On Saturday, health authorities decided to ease social distancing to Level 2 ― the third highest in a five-tier system ― for the greater Seoul metropolitan area and Level 1.5 for other areas, for two weeks starting Monday.Authorities also decided to ease restrictions on restaurants and other public faciliti

Feb 14, 2021
COVID-19 cases in 300s for 2nd day ahead of eased distancing
  • Gov't to ease social distancing, retains ban on gatherings of 5 or more
  • Recovery of pandemic-hit labor market tipped to be modest: Bank of Korea
previous page
256257258259260
next page

Most Read in South Korea